Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

3D cultured spheroids could drive precision treatment for ovarian cancer

Honeycomb-like arrays of tiny, lab-grown cancers could one day help doctors zero in on individualized treatments for ovarian cancer, an unpredictable disease that kills more than 14,000 women each year in the United States alone.

9 Nov 2017

Study links dietary intake of isoflavones with elevated risk of advanced prostate cancer

Dietary intake of isoflavones was linked with an elevated risk of advanced prostate cancer in a recent International Journal of Cancer study. No statistically significant associations were observed between the intake of isoflavones and non-advanced prostate cancer.

8 Nov 2017

Women with history of infertility have increased risk of death, study shows

Women with a history of infertility have a 10 percent increased risk of death compared to those without reported infertility struggles, according to results of a new study from researchers at the Perelman School of Medicine at the University of Pennsylvania.

1 Nov 2017

PARP inhibitors may have efficacy in selected TNBC patients outside of germline BRCA mutation

The investigational PARP inhibitor talazoparib caused regression of patient-derived xenografts (PDXs) of triple-negative breast cancers (TNBC) that had BRCA mutations and also those that did not have BRCA mutations but had other alterations in DNA damage-repair pathways.

1 Nov 2017

Non-invasive diagnostic tool developed for early detection of ovarian cancer

Investigators from Brigham and Women's Hospital and Dana-Farber Cancer Institute are leveraging the power of artificial intelligence to develop a new technique to detect ovarian cancer early and accurately.

31 Oct 2017

Researchers uncover surprising immune cell activity that may explain limitations of immunotherapy

Researchers have uncovered a surprising process within a key immune cell that may help explain the limitations of immunotherapy as a cancer treatment.

31 Oct 2017

Genomic roots of ovarian tumors may arise in fallopian tubes, study suggests

Some scientists have suspected that the most common form of ovarian cancer may originate in the fallopian tubes, the thin fibrous tunnels that connect the ovaries to the uterus.

24 Oct 2017

Gene circuit can be used to switch on inside cancer cells and stimulate immune attack, study suggests

A new study, conducted by researchers at MIT, suggests that a recently developed synthetic gene circuit can stimulate the immune system to kill cancer cells when it identifies indications of the cancer. The gene circuit will only stimulate a therapeutic response when it identifies two particular cancer markers.

20 Oct 2017

UGA researchers pinpoint factors that drive sharp rise in breast cancer genetic testing

A sharp rise in the number of women seeking BRCA genetic testing to evaluate their risk of developing breast cancer was driven by multiple factors, including celebrity endorsement, according to researchers at the University of Georgia.

20 Oct 2017

New CAR-T cell therapy offers effective option for certain blood cancer patients

Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis is one of the first centers nationwide to offer a new immunotherapy that targets certain blood cancers.

19 Oct 2017

Small RNA molecules trigger cancer cells to commit suicide

Small RNA molecules originally developed as a tool to study gene function trigger a mechanism hidden in every cell that forces the cell to commit suicide, reports a new Northwestern Medicine study, the first to identify molecules to trigger a fail-safe mechanism that may protect us from cancer.

19 Oct 2017

Scientists receive critical funding to study treatments for three deadly cancers

Immunotherapy for leukemia patients has been nothing short of a miracle. Now scientists hope to use that science and other forms of gene therapy to tackle three of the deadliest forms of cancer: glioblastoma (brain cancer), sarcoma (bone cancer) and ovarian cancer.

17 Oct 2017

Most ovarian cancers start in the fallopian tubes, study finds

Most - and possibly all - ovarian cancers start, not in ovaries, but instead in the fallopian tubes attached to them.

17 Oct 2017

Higher level of tumor-infiltrating lymphocytes linked to better survival for ovarian cancer patients

A group of international cancer researchers led by investigators from Mayo Clinic and University of New South Wales Sydney has found that the level of a type of white blood cell, called tumor-infiltrating lymphocytes, present in the tumors of patients with high-grade ovarian cancer may predict a patient's survival.

12 Oct 2017

New generation of drugs targets cancer cells’ vulnerability with broken genes

In recent years, new cancer treatments have brought hope to people who once had limited options. But for others, the wait for an effective drug continues.

12 Oct 2017

Research finds higher rates of cancer in world's ‘better’ countries

The world's "better" countries, with greater access to healthcare, experience much higher rates of cancer incidence than the world's "worse off" countries, according to new research from the University of Adelaide.

11 Oct 2017

Drug approved to treat parasitic infections also exerts anti-tumor effect on EOC cells

Osaka Researchers, in partnership with other Japanese and U.S. scientists, report a new gene target, KPNB1, for treatment against epithelial ovarian cancer (EOC).

28 Sep 2017

Notre Dame's HCRI publishes two papers involving ovarian cancer research

Two papers involving ovarian cancer research at the University of Notre Dame's Harper Cancer Research Institute, one featuring new research and the other a review article, were published as cover stories in their respective journals.

27 Sep 2017

Researchers discover mechanism of drug resistance for ovarian and breast cancer cells

Researchers from the People's Friendship University of Russia have studied the mechanism of drug resistance for ovarian and breast cancer cells.

22 Sep 2017

MIT engineers design more effective synthetic mRNA delivery system

By delivering strands of genetic material known as messenger RNA into cells, researchers can induce the cells to produce any protein encoded by the mRNA. This technique holds great potential for administering vaccines or treating diseases such as cancer, but achieving efficient delivery of mRNA has proven challenging.

21 Sep 2017

Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

3D cultured spheroids could drive precision treatment for ovarian cancer

Study links dietary intake of isoflavones with elevated risk of advanced prostate cancer

Women with history of infertility have increased risk of death, study shows

PARP inhibitors may have efficacy in selected TNBC patients outside of germline BRCA mutation

Non-invasive diagnostic tool developed for early detection of ovarian cancer

Researchers uncover surprising immune cell activity that may explain limitations of immunotherapy

Genomic roots of ovarian tumors may arise in fallopian tubes, study suggests

Gene circuit can be used to switch on inside cancer cells and stimulate immune attack, study suggests

UGA researchers pinpoint factors that drive sharp rise in breast cancer genetic testing

New CAR-T cell therapy offers effective option for certain blood cancer patients

Small RNA molecules trigger cancer cells to commit suicide

Scientists receive critical funding to study treatments for three deadly cancers

Most ovarian cancers start in the fallopian tubes, study finds

Higher level of tumor-infiltrating lymphocytes linked to better survival for ovarian cancer patients

New generation of drugs targets cancer cells’ vulnerability with broken genes

Research finds higher rates of cancer in world's ‘better’ countries

Drug approved to treat parasitic infections also exerts anti-tumor effect on EOC cells

Notre Dame's HCRI publishes two papers involving ovarian cancer research

Researchers discover mechanism of drug resistance for ovarian and breast cancer cells

MIT engineers design more effective synthetic mRNA delivery system

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in